Related Experiment Video
Updated: Aug 11, 2026
07:11
Assessment of the Efficacy of An Osteopathic Treatment in Infants with Biomechanical Impairments to Suckling
Published on: February 5, 2019
[Management of chronic constipation in the infant]
1Service de gastroentérologie et nutrition pédiatriques, hôpital Necker-Enfants-Malades, Paris, France.
Summary
Constipation, often chronic idiopathic constipation, stems from intestinal motility issues. Management involves fecal evacuation, preventative measures like diet and hydration, and parental reassurance.
Area of Science:
- Gastroenterology
- Pediatric Gastroenterology
- Digestive Health
Context:
- Constipation is a prevalent symptom linked to intestinal motility disorders.
- Chronic idiopathic constipation is the most common form encountered.
- Organic diseases like Hirschsprung disease are suspected in severe or refractory cases.
Purpose:
- To outline the diagnostic approach and management strategies for constipation, particularly in pediatric populations.
- To differentiate between functional and organic causes of constipation.
- To provide guidance on treating chronic idiopathic constipation.
Summary:
- Constipation arises from intestinal dysmotility, with chronic idiopathic constipation being most frequent.
- Investigations for organic causes are reserved for specific red flag symptoms or treatment resistance.
- Management focuses on initial fecal disimpaction followed by long-term strategies including diet, hydration, and lifestyle modifications.
Impact:
- Provides a clear framework for diagnosing and managing constipation in clinical practice.
- Emphasizes conservative management for chronic idiopathic constipation, reducing unnecessary investigations.
- Highlights the importance of parental education and reassurance in successful treatment outcomes.
Related Concept Videos
01:20Drugs Affecting GI Tract Motility: Other Laxatives
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:21Drugs for Treatment of Constipation-Predominant IBS
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
01:21Inflammatory Bowel Disease V: Surgical Management
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD: